Barbara W Marley, APRN BC CS in Natchitoches, LA - Clinical Nurse Specialist

Barbara W Marley, APRN BC CS is a Clinical Nurse Specialist - Psychiatric/mental Health, Adult based in Natchitoches, Louisiana. Barbara W Marley is licensed to practice in Louisiana (license number AP03752) and her current practice location is 111 E 5th St, Room 212, Natchitoches, Louisiana. She can be reached at her office (for appointments etc.) via phone at (318) 664-4913.

NPI number for Barbara W Marley is 1942291828 and her current mailing address is 242b Keyser Ave, Pmb 280, Natchitoches, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1942291828.

Contact Information

	Barbara W Marley, APRN BC CS
	111 E 5th St, Room 212, Natchitoches, LA 71457-5724
	(318) 664-4913
	(318) 354-1805

Provider's Profile

Full Name	Barbara W Marley
Gender	Female
Speciality	Clinical Nurse Specialist - Psychiatric/mental Health, Adult
Location	111 E 5th St, Natchitoches, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1942291828
Provider Enumeration Date: 10/31/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Barbara W Marley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942291828	NPI	-	NPPES
1625078	Medicaid	LA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364S00000X	Clinical Nurse Specialist	RN098474 (Louisiana)	Primary
364SP0807X	Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent	AP03752 (Louisiana)	Primary
364SP0809X	Clinical Nurse Specialist - Psychiatric/mental Health, Adult	AP03752 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Barbara W Marley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Barbara W Marley, APRN BC CS 242b Keyser Ave, Pmb 280, Natchitoches, LA 71457-5102 Ph: (318) 664-4913	Barbara W Marley, APRN BC CS 111 E 5th St, Room 212, Natchitoches, LA 71457-5724 Ph: (318) 664-4913

News Archive

Inhibiting STAT3 might unleash an effective anti-lymphoma immune response

Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsible for disease relapse.

DATATRAK third quarter revenue increases 17% to $1,818,000

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the third quarter of 2010: $1.8 million revenue, $11.4 million backlog, and continued profitability, resulting in a cash increase over second quarter 2010.

Men with ASD have differences in brain connections

Research at King's College London has revealed subtle brain differences in adult males with autism spectrum disorder (ASD), which may go some way towards explaining why symptoms persist into adulthood in some people with the disorder.

Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VPRIV (velaglucerase alfa), an enzyme replacement therapy (ERT) for long-term use in pediatric and adult type 1 Gaucher disease.

Study: Dab2 can exhibit neuroprotective effects in Alzheimer's by regulating TGF-β1/SMAD signaling

Transforming growth factor-beta (TGF-β) type II receptor (TβRII) levels are extremely low in the brain tissue of patients with Alzheimer's disease.

Barbara W Marley, APRN BC CS - Clinical Nurse Specialist in Natchitoches, LA